-+ 0.00%
-+ 0.00%
-+ 0.00%

IMMIX BIOPHARMA, - NET PROCEEDS TO FUND NXC-201 DEVELOPMENT, WORKING CAPITAL, CORPORATE PURPOSES

Reuters·09/29/2026 11:07:42